Bristol-Myers Squibb buy Piper Sandler
Start price
23.02.26
/
50%
€51.31
Target price
23.02.27
€63.41
Performance (%)
-1.13%
Price
08.04.26
€50.73
Summary
This prediction is currently active. With a performance of -1.13%, the BUY prediction for Bristol-Myers Squibb by Piper_Sandler is down slightly. This prediction currently runs until 23.02.27. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | -5.231% | -5.231% |
| iShares Core DAX® | 0,23 % | -2,41 % |
| iShares Nasdaq 100 | 1,66 % | -1,66 % |
| iShares Nikkei 225® | -0,21 % | -2,50 % |
| iShares S&P 500 | 1,07 % | -1,58 % |
Comments by Piper_Sandler for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $75.00 price target on the stock, up previously from $66.00.
Ratings data for BMY provided by MarketBeat